BillsBills 119th Congress S. 652 S. 652 · Senate bill · 119th Congress
Protecting Patients from Deceptive Drug Ads Act Introduced Feb 20, 2025 In committee Feb 20, 2025 Health, Education, Labor, and Pensions Passed the Senate (not yet) Passed the House (not yet) Law (not yet) What it would change (2) About this text
2 sections of the Code · 2 changes asked for
Text: introduced in Senate Introduced The text as a member of Congress first filed it. Most bills never get further than this. , Feb 20, 2025 (the only version so far)
Official text on Congress.gov
Written by AIWhat this bill would change in the Code
The bill would add civil penalties for social media influencers and health care providers who are paid to promote a prescription drug, including compounded drugs, with posts that knowingly or recklessly contain a false statement or leave out important information, or that omit the required brief summary of side effects, contraindications and effectiveness. Care by professionals, research, and a person's own experience or opinion would be excluded. It would also extend the prescription drug advertising rules to anyone who issues an ad for a prescription or compounded drug and offers to connect patients with a prescriber or dispenser online, such as a telehealth company. Private communications between a licensed prescriber and a patient would be excluded.
Summed up from the notes on the 2 sections the bill would change. It covers only changes to the Code. No person has checked it, and it can be wrong. The changes themselves are what the bill would do. About these notes
Sections are cited like “7 U.S.C. § 2012”: title Title One of the 54 subject areas the Code is divided into, such as Title 7 (Agriculture) or Title 26 (taxes). A title is split into chapters. 7 of the United States Code U.S.C. (United States Code) The United States Code: the federal laws in force, arranged by subject. "4 U.S.C. § 8" means title 4, section 8. , section Section (§) The basic unit of the Code, marked §. Each section has a number within its title and is cited like "7 U.S.C. § 2012". 2012.
21 U.S.C. Chapter 9 · Federal Food, Drug, and Cosmetic Act 2 sections § 333 Penalties Shown § 352 Misbranded drugs and devices Shown